Literature DB >> 1360809

Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.

A Viel1, F Giannini, L Tumiotto, F Sopracordevole, M C Visentin, M Boiocchi.   

Abstract

In this study, 44 primary or metastatic human ovarian tumours were tested for allelic deletions on the short arm of chromosome 11. Analysis of 12 polymorphic loci by Southern blotting evidenced loss of heterozygosity (LOH) in at least one locus in 41% of cases. Moreover, two hot spots of deletions were tentatively mapped on 11p13 and 11p15.5. Our results demonstrated that LOH at 11p is a common event in ovarian carcinomas and were indicative of the possible existence in 11p of two oncosuppressor genes involved in ovarian carcinogenesis. The similarity observed with 11p allelic losses in Wilms tumours, clustered in 11p13 and 11p15.5 too, suggests that deletion and possibly inactivation of the same growth regulatory genes (WT genes) could also contribute to development of the malignant phenotype in ovarian carcinomas. Finally, a statistically significant association (P = 0.005) between 11p deletions and hepatic involvement was suggested by the analysis of distribution of 11p LOH relative to different clinical and pathological parameters of the tumour patients.

Entities:  

Mesh:

Year:  1992        PMID: 1360809      PMCID: PMC1978017          DOI: 10.1038/bjc.1992.405

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer.

Authors:  C U Ludwig; G Raefle; P Dalquen; P Stulz; R Stahel; J P Obrecht
Journal:  Int J Cancer       Date:  1991-11-11       Impact factor: 7.396

2.  A systematic approach for detecting high-frequency restriction fragment length polymorphisms using large genomic probes.

Authors:  J Feder; L Yen; E Wijsman; L Wang; L Wilkins; J Schroder; N Spurr; H Cann; M Blumenberg; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.

Authors:  A Okamoto; Y Sameshima; S Yokoyama; Y Terashima; T Sugimura; M Terada; J Yokota
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

4.  Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification.

Authors:  J P Zheng; W R Robinson; T Ehlen; M C Yu; L Dubeau
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

5.  Allele loss at the retinoblastoma locus in human ovarian cancer.

Authors:  S B Li; P E Schwartz; W H Lee; T L Yang-Feng
Journal:  J Natl Cancer Inst       Date:  1991-05-01       Impact factor: 13.506

6.  Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood.

Authors:  P Devilee; M van den Broek; M Mannens; R Slater; C J Cornelisse; A Westerveld; P M Khan
Journal:  Int J Cancer       Date:  1991-04-01       Impact factor: 7.396

7.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Authors:  J Pelletier; W Bruening; C E Kashtan; S M Mauer; J C Manivel; J E Striegel; D C Houghton; C Junien; R Habib; L Fouser
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

8.  Expression of the Wilms' tumor gene WT1 in the murine urogenital system.

Authors:  J Pelletier; M Schalling; A J Buckler; A Rogers; D A Haber; D Housman
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

9.  K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.

Authors:  T Enomoto; C M Weghorst; M Inoue; O Tanizawa; J M Rice
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

10.  Allelotype of human ovarian cancer.

Authors:  T Sato; H Saito; R Morita; S Koi; J H Lee; Y Nakamura
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

View more
  12 in total

1.  Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

Authors:  M Gaitanou; P Buanne; C Pappa; N Georgopoulou; A Mamalaki; F Tirone; R Matsas
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  The long and short of chromosome 11 in breast cancer.

Authors:  I F Newsham
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

3.  Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.

Authors:  K Yun; M Fukumoto; Y Jinno
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

4.  Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.

Authors:  Y Hatta; S Takeuchi; J Yokota; H P Koeffler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

6.  Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples.

Authors:  C Schwienbacher; S Sabbioni; M Campi; A Veronese; G Bernardi; A Menegatti; I Hatada; T Mukai; H Ohashi; G Barbanti-Brodano; C M Croce; M Negrini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Polymerase chain reaction allelotyping of human ovarian cancer.

Authors:  R J Osborne; V Leech
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

8.  Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.

Authors:  Lydia Quaye; Jonathan Tyrer; Susan J Ramus; Honglin Song; Eva Wozniak; Richard A DiCioccio; Valerie McGuire; Estrid Høgdall; Claus Høgdall; Jan Blaakaer; Ellen L Goode; Joellen M Schildkraut; Douglas F Easton; Susanne Krüger-Kjaer; Alice S Whittemore; Simon A Gayther; Paul D P Pharoah
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

9.  Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

Authors:  H Gabra; L Taylor; B B Cohen; A Lessels; D M Eccles; R C Leonard; J F Smyth; C M Steel
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

10.  Characterisation of seven human ovarian tumour cell lines.

Authors:  A P Wilson; M Dent; T Pejovic; L Hubbold; H Radford
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.